Crestor

AstraZeneca offloads former crown jewel Crestor as it continues to refocus on oncology drugs
AstraZeneca offloads former crown jewel Crestor as it continues to refocus on oncology drugs
Endpoints
AstraZeneca
Crestor
Europe
Grunenthal
M&A
Flag link:
What to Expect for AstraZeneca in Fiscal 2018
What to Expect for AstraZeneca in Fiscal 2018
Market Realist
AstraZeneca
guidance
generics
Crestor
Japan
Europe
Flag link:
AstraZeneca Stock Gains as Crestor Sales Decline Slows
AstraZeneca Stock Gains as Crestor Sales Decline Slows
TheStreet.com
AstraZeneca
earnings
Crestor
Flag link:
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
Flag link:
Will AstraZeneca plc (ADR) Survive Crestor Patent Expiration?
Will AstraZeneca plc (ADR) Survive Crestor Patent Expiration?
Bidness, ETC
AstraZeneca
Crestor
patents
Flag link:
How Crestor Weakened AstraZeneca’s CVMD Segment in 2Q16
How Crestor Weakened AstraZeneca’s CVMD Segment in 2Q16
Market Realist
Crestor
AstraZeneca
Flag link:
AstraZeneca plc (ADR) Q2 Earnings: Crestor’s Patent Loss to Hit Hard
AstraZeneca plc (ADR) Q2 Earnings: Crestor’s Patent Loss to Hit Hard
Bidness, ETC
earnings
Crestor
AstraZeneca
Flag link:
AstraZeneca's bid to protect Crestor fails as judge refuses to block new generics
AstraZeneca's bid to protect Crestor fails as judge refuses to block new generics
Fierce Pharma
AstraZeneca
Crestor
generics
Flag link:
Judge sets late-breaking rules for AstraZeneca's last stand on Crestor
Judge sets late-breaking rules for AstraZeneca's last stand on Crestor
Fierce Pharma
AstraZeneca
generics
Crestor
Flag link:
Democrats exhort FDA to approve generic versions of Crestor
Democrats exhort FDA to approve generic versions of Crestor
BioPharma Dive
Democrats
FDA
generics
Crestor
AstraZeneca
Flag link:
How Will AstraZeneca (AZN) Stock Be Affected by Generic Copies?
How Will AstraZeneca (AZN) Stock Be Affected by Generic Copies?
TheStreet.com
AstraZeneca
generics
Crestor
Flag link:
AstraZeneca sues FDA to prevent generic versions of Crestor
AstraZeneca sues FDA to prevent generic versions of Crestor
Stat
AstraZeneca
Crestor
FDA
generics
patents
Flag link:
AstraZeneca files Hail Mary petition urging FDA to block more Crestor generics till 2023
AstraZeneca files Hail Mary petition urging FDA to block more Crestor generics till 2023
Fierce Pharma
AstraZeneca
FDA
Crestor
generics
Flag link:
Just When FDA Thought It Was Out, They Pull It Back In: AstraZeneca Raises 505A(o) and Orphan Drug Exclusivity Carve-Outs in CRESTOR Petition
Just When FDA Thought It Was Out, They Pull It Back In: AstraZeneca Raises 505A(o) and Orphan Drug Exclusivity Carve-Outs in CRESTOR Petition
FDA Law Blog
FDA
orphan drugs
Crestor
505A(o)
Flag link:
Crestor tumbles off patent cliff as first generic copy approved in US
Crestor tumbles off patent cliff as first generic copy approved in US
BioPharma Dive
Crestor
patents
patent cliff
generics
AstraZeneca
Watson Pharmaceuticals
Flag link:
Crestor Developer Sees Sales Doubling On Lower-Priced Drugs
Crestor Developer Sees Sales Doubling On Lower-Priced Drugs
Bloomberg
Crestor
drug pricing
Shionogi
Flag link:
Cholesterol-lowering statins cut heart disease risk in people with slightly high blood pressure
Cholesterol-lowering statins cut heart disease risk in people with slightly high blood pressure
Stat
statins
hypertension
Crestor
AstraZeneca
Flag link:
AstraZeneca warns on profits in 2016 as Crestor patent loss weighs
AstraZeneca warns on profits in 2016 as Crestor patent loss weighs
Reuters
earnings
AstraZeneca
Crestor
Flag link:
Patent Expirations Of Crestor And Zetia And The Impact On Other Cholesterol Drugs
Patent Expirations Of Crestor And Zetia And The Impact On Other Cholesterol Drugs
Forbes
patents
Crestor
Zetia
AstraZeneca
Merck
Flag link:
op-selling drugs might be first in line for Medicare price negotiations
op-selling drugs might be first in line for Medicare price negotiations
Fierce Pharma
Medicare
drug pricing
Hillary Clinton
GSK
Advair
AstraZeneca
Crestor
Merck
Januvia
Sanofi
Lantus
Celgene
Revlimid
Flag link:

Pages